Tirsel

Tirsel is an early-stage biotechnology company focused on developing next-generation immunotherapies for cancer and autoimmune diseases. The company leverages a proprietary platform designed to redirect and enhance T-cell responses against specific disease targets. By utilizing advanced engineering techniques, Tirsel aims to create highly specific cell therapies and antibody-based treatments that overcome the limitations of current immunotherapeutic approaches. The company's research is centered on optimizing the interaction between the immune system and diseased cells to provide more durable and effective clinical outcomes.